Clinical Trial Update: National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating mesenchymal stem cell therapy for non-viral acute-on-chronic liver failure; currently not yet recruiting, sponsored by the In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Acute-On-Chronic Liver Failure | Phase 2 | Status: NOT_YET_RECRUITING